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Cytoplasmic polyadenylation of mRNAs is involved in post-transcriptional regulation of genes, including translational activation. In
addition to yeast Cid1 and Cid13 and mouse TPAP, GLD-2 has been recently identified as a cytoplasmic poly(A) polymerase in
Caenorhabditis elegans and Xenopus oocytes. In this study, we have characterized mouse GLD-2, mGLD-2, in adult tissues, meiotically
maturing oocytes, and NIH3T3 cultured cells. mGLD-2 was ubiquitously present in all tissues and cells tested. mGLD-2 was localized in the
nucleus as well as in the cytoplasm of somatic, testicular, and cultured cells. Transfection of expression plasmids encoding mGLD-2 and the
mutant proteins into NIH3T3 cells revealed that a 17-residue sequence in the N-terminal region of mGLD-2 probably acts as a localization
signal required for the transport into the nucleus. Analysis of reverse transcriptase-polymerase chain reaction indicated the presence of mGLD-
2 mRNA in the oocytes throughout meiotic maturation. However, 54-kDa mGLD-2 was found in the oocytes only at the metaphases I and II
after germinal vesicle breakdown, presumably due to translational control. When mGLD-2 synthesis was artificially inhibited and enhanced by
injection of double-stranded and polyadenylated RNAs into the germinal vesicle-stage oocytes, respectively, oocyte maturation was
significantly arrested at the metaphase-I stage. These results suggest that mGLD-2 may act in the ooplasm on the progression of metaphase I to
metaphase II during oocyte maturation.
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Polyadenylation of mRNA precursors initially occurs in the
nucleus of eukaryotic cells, and the polyadenylated mRNAs are
then transported into the cytoplasm. The processing of the
mRNA precursors at the 3V-end is one of the post-transcriptional
gene regulations because the length of the poly(A) tail is
implicated in various aspects of mRNA metabolism, including
the transport of mRNAs into the cytoplasm,mRNA stability, and
translational control of mRNAs (Sachs et al., 1997; Wickens et
al., 1997). In particular, the lengthening, maintenance, and
shortening of the poly(A) tails in the cell cytoplasm are essential0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: acroman@sakura.cc.tsukuba.ac.jp (T. Baba).for modulation of gametogenesis (Kashiwabara et al., 2000,
2002; Wang et al., 2002) and early embryonic development
(Kuersten and Goodwin, 2003; Richter, 1999); for instance,
meiotic maturation of Xenopus and mouse oocytes has been
reported to require cytoplasmic polyadenylation of c-mos
mRNA for synthesis of the Mos protein responsible for the
stabilization and activation of maturation promoting factor MPF
(Colledge et al., 1994; Gebauer et al., 1994; Hashimoto et al.,
1994; Sheets et al., 1995).
In Xenopus oocytes, cytoplasmic polyadenylation is
controlled by several core factors: CPEB (Hake et al., 1998;
Mendez and Richter, 2001), CPSF (Bilger et al., 1994;
Dickson et al., 1999), and maskin (Cao and Richter, 2002;
Stebbins-Boaz et al., 1999) capable of binding to the
cytoplasmic polyadenylation element UUUUA/UAU (CPE),
to the polyadenylation hexanucleotide AAUAAA, and to both89 (2006) 115 – 126
www.e
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protein, eIF4E, respectively. When Eg2, a member of the
aurora Ser/Thr protein kinase family, phosphorylates the Ser-
174 residue in CPEB, the interaction between the AAUAAA
element and CPSF is presumably stabilized by phosphorylat-
ed CPEB, leading to the recruitment of poly(A) polymerase
(PAP) to the 3V-end of mRNA (Mendez and Richter, 2001). In
addition to the above core factors, two novel proteins
essential for cytoplasmic polyadenylation have been recently
identified: CPEB- and CPSF-binding protein symplekin and
cytoplasmic PAP GLD-2 that act as scaffold and anchored
proteins in the cytoplasmic polyadenylation machinery,
respectively (Barnard et al., 2004). Thus, the molecular
mechanism of cytoplasmic polyadenylation has been defined
in Xenopus oocytes. However, little is known of the
mechanism in the mammalian oocytes.
Despite the presence of the protein complex governing
cytoplasmic polyadenylation, PAP is the sole enzyme capable
of elongating poly(A) tail at the 3V-end of mRNA. Several
cytoplasmic PAPs, Cid1 (Read et al., 2002; Wang et al.,
2000), Cid13 (Read et al., 2002; Saitoh et al., 2002), and
GLD-2 (Barnard et al., 2004; Wang et al., 2002), which are
structurally distinguishable from nuclear PAP (Martin et al.,
2000, 2004; Raabe et al., 1991, 1994; Thuresson et al., 1994;
Wahle, 1991; Zhao and Manley, 1996), have been character-
ized in yeast, Caenorhabditis elegans, and Xenopus. Yeast
Cid13 participates in DNA replication and genome mainte-
nance (Saitoh et al., 2002), while yeast Cid1 and C. elegans
GLD-2 are involved in the cell cycle control such as the
inhibition of mitosis and entry into meiosis (Kadyk and
Kimble, 1998; Read et al., 2002; Wang et al., 2000). In
mammalian cells, five PAPs have been identified: canonical
PAP (PAPI and PAPII) (Raabe et al., 1991, 1994; Thuresson
et al., 1994; Zhao and Manley, 1996), TPAP (Kashiwabara et
al., 2000, 2002), neo-PAP/PAPg (Kyriakopoulou et al., 2001;
Topalian et al., 2001), GLD-2 (Kwak et al., 2004; Rouhana
et al., 2005; Wang et al., 2002), and nuclear-encoded
mitochondrial PAP, mitoPAP (Tomecki et al., 2004). These
mammalian PAPs except TPAP, GLD-2, and mitoPAP are
exclusively localized in the nucleus. Only TPAP in spermato-
genic cells (Kashiwabara et al., 2000, 2002) is characterized
as a cytoplasmic PAP among mammalian PAPs, and the
subcellular localization of GLD-2 in mammalian cells has not
yet been ascertained. Moreover, the biological roles of
mammalian PAPs except TPAP are still uncertain, although
these PAPs all exhibit the polyadenylation activity.
In this study, we have demonstrated that mouse GLD-2,
termed mGLD-2, is a PAP localized in both cytoplasm and
nucleus of somatic, testicular, and cultured cells. However,
mGLD-2 is synthesized in the cytoplasm of mouse oocytes
following germinal vesicle breakdown (GVBD) because the
GLD-2 mRNA is under translational control at the early
stages of oocyte maturation. Both impaired and enhanced
productions of mGLD-2 significantly result in the oocyte
arrest at the metaphase-I stage. Thus, mGLD-2 may function
in the progression of metaphase I to metaphase II during
oocyte maturation.Materials and methods
Polymerase chain reaction (PCR)
An unfertilized mouse oocyte cDNA library was prepared from total
cellular RNA of metaphase II-arrested mouse oocytes using a HybriZAP-2.1
XR library construction kit (Stratagene). A DNA fragment encoding mGLD-2
(GenBank/EBI accession number NM_133905) was amplified by PCR using
the cDNA library as a template. The following oligonucleotides were used as
primers: SEP5 (5V-TTCCATGGTCCCAAACTCAATTTTGGGT-3V) and SEP19
(5V-AAGTCGACTTATCTTTTCAGGGTAGCAGC-3V). Reactions were per-
formed in a 50-Al mixture containing 10 mM Tris/HCl, pH 8.8, 50 mM KCl,
1.5 mM MgCl2, 0.1% Triton X-100, 0.2 mM each of dATP, dCTP, dGTP, and
dTTP, 1 AM each of primers, template cDNA, and 2 units of Taq DNA
polymerase (Nippon Gene, Toyama, Japan). The reaction program consisted of
35 cycles of 94-C for 60 s, 60-C for 60 s, and 72-C for 120 s. The PCR product
was then introduced into a pTV119N vector (Takara Bio Inc., Shiga, Japan) at
NcoI and SalI sites. DNA fragments were also PCR-amplified from a mouse
testis cDNA library (Kashiwabara et al., 1990) using following oligonu-
cleotides as primers: SEP50, 5V-TCGGCCCTTCGGCGTGGACG-3V; SEP12,
5V-TGTCGACTGTAGGCCTACAAGAAGTT-3V; SEP11, 5V-TGGATCCA-
GATCTGAACAGTGTGCTGC-3V; SEP53, 5V-CACGATTAGGTTCCGAT-
CAG-3V; SEP7, 5V-AAGTCGACACTTGCTTGCTGCTGACAA-3V; SEP46, 5V-
CAGAGCTGTGCATGAGAAGC-3V; SEP18, 5V-AGCAACCTCCAGAG-
TCTATC-3V. Nucleotide sequencing was carried out using an ABI Prism 310
genetic analyzer.
Northern blot analysis
Total cellular RNAs were extracted from various tissues and cells using
Isogen (Nippon Gene), as described previously (Kashiwabara et al., 2000).
The RNA samples were glyoxylated, separated by electrophoresis on 1.2%
agarose gels, and transferred onto Hybond-N+ nylon membranes (Amersham
Biosciences). The blots were probed by 32P-labeled DNA fragments and
analyzed by autoradiography or a BAS-1800II Bio-Image Analyzer (Fuji
Photo Film, Tokyo, Japan).
Preparation of cytoplasmic and nuclear extracts
Mouse tissues (0.5 g each) were homogenized at 4-C in 5 ml of 10 mM
HEPES/KOH, pH 7.4, containing 15 mM KCl, 1 mM EDTA, 0.25 M
sucrose, 0.5 mM dithiothreitol, 0.5 mM phenylmethanesulfonyl fluoride,
pepstatin A (1 Ag/ml), leupeptin (1 Ag/ml), and 1 mM benzamidine with a
Teflon-glass homogenizer at 800 rpm (5 strokes). The homogenate was
centrifuged at 2500  g for 10 min at 4-C. The supernatant was further
centrifuged at 15,000  g for 20 min, and the resulting supernatant was used
as ‘‘cytoplasmic extract.’’ The precipitate obtained by the first centrifugation
was suspended in the above buffer (5 ml), overlaid onto the same buffer
(5 ml) containing 0.5 M sucrose, and centrifuged at 2500  g for 10 min at
4-C. This treatment was repeated three times, and the remaining pellet was
resuspended in the same buffer (1 ml) containing 0.5 M NaCl, mixed gently
for 1 h, and then centrifuged at 90,000  g for 1 h at 4-C. The supernatant
solution was used as ‘‘nuclear extract.’’ Nuclear and cytoplasmic extracts of
NIH3T3 cells were prepared by using a PARIS kit (Ambion) according to the
manufacturer’s protocol. Protein concentration was determined using a
Coomassie protein assay reagent kit (Pierce).
Antibodies
Two DNA fragments encoding the C-terminal 149- and 62-residue
sequences of mGLD-2 were PCR-amplified, introduced into pET-23d (Nova-
gen) and pGEX-4T-1 (Amersham Biosciences), respectively, and expressed in
Escherichia coli BL21 (DE3). The 149-residue protein tagged with six His was
purified on an Ni-NTA His column (Novagen), emulsified with Freund’s
complete adjuvant (Difco Laboratories), and injected intradermally into female
New Zealand White rabbits (SLC Inc., Shizuoka, Japan). Following fraction-
ation of antisera with ammonium sulfate (0–40% saturation), anti-mGLD-2
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with the above 62-residue protein fused to glutathione S-transferase, as
described previously (Honda et al., 2002). Antibodies against h-tubulin
(T5293), FLAG, histone deacetylase 2 (HDAC2, H-54), and hemagglutinin
(HA) were purchased from Sigma (St. Louis, MO), Stratagene (La Jolla, CA),
Santa Cruz Biotechnology (Santa Cruz, CA), and Roche Diagnostics
(Indianapolis, IN), respectively.
Immunoblot analysis
Proteins were separated by SDS-polyacrylamide gel electrophoresis
(PAGE) and transferred onto Immobilon-P polyvinylidene difluoride mem-
branes (Millipore). After blocking with 2% skim milk, the blots were probed by
primary antibodies and then incubated with secondary antibodies conjugated
with horseradish peroxidase (Jackson Immunoresearch Laboratories). The
immunoreactive proteins were visualized by an ECLWestern blotting detection
kit (Amersham Biosciences), as described (Nishimura et al., 2004).
Measurement of enzyme activity
Recombinant proteins were produced in vitro by using a TNT Quick
Coupled Transcription/Translation system (Promega), as described previously
(Kashiwabara et al., 2000). Poly(A) polymerase activity was determined by
measuring incorporation of AMP from [a-32P]ATP (400 Ci/mmol, Amersham
Biosciences) into oligo(A)12 RNA primer in the presence of MnCl2
(Kashiwabara et al., 2000; Zhao and Manley, 1996). The reaction mixture
(50 Al) consisted of 50 mM Tris/HCl, pH 8.3, 7% glycerol, 0.3% polyvinyl
alcohol, 40 mM KCl, 0.5 mM MnCl2, 25 mM (NH4)2SO4, 0.25 mM
dithiothreitol, 0.1 mM [a-32P]ATP (600 cpm/pmol), 2 Ag oligo(A)12, and an
aliquot of in vitro translation product. After incubation at 30-C, aliquots (3 Al)
were spotted onto Whatman DE-81 paper, dried, and washed five times with
0.1 M phosphate buffer, pH 7.0, and once with ethanol. Incorporation of 32P-
labeled AMP was then measured by liquid scintillation counting.
Cell culture
NIH3T3 cells were transfected with expression plasmids using a FuGENE 6
transfection reagent (Roche Diagnostics) and cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum, 100 units/ml
penicillin, and 0.1 mg/ml streptomycin at 37-C under 5% CO2 in air. After 48-h
incubation, cells were observed under an Olympus IX-70 epifluorescent
microscope.
RNA synthesis in vitro
DNA fragments were introduced into a pcDNA3.1 vector, and the resulting
plasmids were linearized by cutting with NotI. RNAs were synthesized by T7
polymerase using a RiboMAX large scale RNA production systems-T7 kit
(Promega) and then polyadenylated by using a Poly(A) tailing kit (Ambion).
The polyadenylated RNAs were extracted with phenol-chloroform, precipitated
with ethanol, and dissolved in water. For preparation of double-stranded RNA
(dsRNA), 628- and 650-bp DNA fragments derived from mGLD-2 and Mos
cDNAs, respectively, were introduced into pBluscriptII SK or KS. The
plasmids were linearized and used as templates for RNA synthesis as described
above. The sense and antisense single-strand RNAs (4 AM each) were then
mixed in 10 mM Tris/HCl buffer, pH 7.4, containing 0.1 mM EDTA, heated at
95-C for 5 min, and kept at room temperature for 16 h. Remaining single-strand
RNA was digested with RNase T1 (2 U/Al) for 30 min at 37-C. dsRNA so
obtained was dissolved in water and stored at 80-C.
Oocyte collection and microinjection
Fully grown, GV-stage oocytes were prepared from ovaries of 8-week-old
ICR mice (SLC Japan) 46–48 h after intraperitoneal injection of pregnant
mare’s serum gonadotropin (Teikokuzoki Co., Tokyo, Japan), as described
previously (Schultz et al., 1983). Cumulus cells attached with the oocytes wereremoved by pipetting. The oocytes were cultured in a 0.2-ml drop of a modified
Krebs–Ringer bicarbonate solution (TYH medium) (Toyoda et al., 1971)
containing 5% fetal bovine serum and 0.24 mM N6,2V-O-dibutyryladenosine
3V:5V-cyclic monophosphate (dbcAMP) (Sigma) at 37-C under 5% CO2 in air.
RNA samples (10 pl) were microinjected into the cytoplasm of the oocytes
using a Femtojet constant flow system (Eppendorf). The oocytes were cultured
in TYH medium containing 5% fetal bovine serum and 0.24 mM dbcAMP,
washed thoroughly with the TYH medium free from dbcAMP, and then
cultured in the same medium. All animal experiments were carried out
according to the Guide for the Care and Use of Laboratory Animals in
University of Tsukuba.
Semi-quantitative PCR
First-strand cDNAwas synthesized from total RNA of 10 oocytes using a full
3V-RACE kit (Takara Bio) according to the manufacturer’s protocol, as described
previously (Ohmura et al., 1999). PCR was carried out using the first-strand
cDNA as a template. The reaction program for mGLD-2 and PAPII consisted of
32 cycles of 94-C for 30 s, 60-C for 30 s, and 72-C for 40 s (29 cycles for Mos
and glyceraldehyde-3-phosphate dehydrogenase, G3PDH). The numbers of the
reaction cycles were determined on the basis of linear regions of the semi-log
plots for the amount of PCR-amplified products. The following oligonucleotides
were used as primers: SEP5 (5V-TTCCATGGTCCCAAACTCAATTTTGGGT-3V)
and SEP7 (5V-AAGTCGACACTTGCTTGCTGCTGACAA-3V) for mGLD-2;
MOS5 (5V-ACTCGAGTTCGTAACTTTATTTCC-3V) and MOS6 (5V-TCAGT-
GACTTCGGCTGCTCC-3V) for Mos; G3PP1 (5V-AGTGGAGATTGTTGCCAT-
CAACGAC-3V) and G3PP2 (5V-GGGAGTTGCTGTTGAAGTCGCAGGA-3V) for
G3PDH; PPP1 (5V-GGAATTCAGACGATGCCGTTTCCAGT-3V) and PPP2 (5V-
GGAATTCCGTAGGTCCAAATCTTCTGG-3V) for PAPII. The PCR products
were separated by agarose gel electrophoresis and quantified by a ChemiDoc
XRS densitometer (Bio-Rad) using a Quantity One software.
Immunohistochemistry
Oocytes were fixed in phosphate-buffered saline (PBS) containing 2%
paraformaldehyde for 30 min and in PBS containing 2% formaldehyde for 1 h,
treated with 1% Triton X-100 in PBS for 15 min, and blocked with PBS
containing 3% goat serum and 0.05% Tween-20 overnight. The oocytes were
then incubated with primary antibodies in the blocking solution for 3 h, washed
with PBS, and reacted with secondary antibodies conjugated with Alexa Fluor
488 or 568 (Molecular Probes, Eugene, OR), as described previously (Kim
et al., 2004). The nuclei of the oocytes were stained with Hoechst 33342. After
washing with PBS containing 0.05% Tween-20, the oocytes were observed
using an Olympus IX-70 inverted microscope equipped with a SPOT RT
camera (Diagnostic Instruments). The 16-bit digital images were analyzed by
using a Metamorph software.
PCR-based poly(A) test (PAT)
Lengths of mRNA poly(A) tails were measured by PAT assays as
described previously (Rassa et al., 2000; Kashiwabara et al., 2002). Briefly,
total RNA from 50 oocytes was ligated to a 32-mer RNA oligonucleotide, 5V-
UACGCAUCAUACGCUGUGGCGUACCUUGUA-3V (60 pmol) and reacted
at 42-C for 50 min with SuperScript II reverse transcriptase (Invitrogen),
using a PAT1 oligonucleotide, 5V-ACAAGGTACGCCACAGCGTATG-3V, as a
primer. A portion of the reaction mixture was subjected to first round PCR
using a set of PAT1 and a gene-specific primer listed below. Second round
PCR was carried out using a nested set of primers, PAT2, 5V-GGCTCGAGG-
TACGCCACAGCGTATGATG-3V, and another gene-specific primer. The PCR
reaction consisted of 20 cycles (30 cycles for the second round PCR) of 94-C
for 30 s, 60-C for 30 s, and 72-C for 30 s. The DNA fragments were
separated on agarose gels and stained with ethidium bromide. The gene-
specific primers used for first and second round PCRs were as follows:
SEP11, 5V-TGGATCCAGATCTGAACAGTGTGCTGC-3V, and SEP44, 5V-
TGCCTTTGAGAGCTGCTACC-3V, for mGLD-2; CYB4, 5V-GGCTTCATT-
CATAGTAGCTC-3V, and CYB3, 5V-TCCTGTCTTGTAATGCCACCTG-3V, for
cyclin B1; MOS10, 5V-AACATCATCCAGAGCTGCTG-3V, and MOS9, 5V-
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CAGTTGC-3V, and CAT1, 5V-AGGTGACAGCATTGCTTCTG-3V, for h-cate-
nin; ACT2, 5V-AGGTGACAGCATTGCTTCTG-3V, and ACT1, 5V-
TTTCTGAATGGCCCAGGTCTG-3V, for h-actin.Results
Although the outlines of mammalian GLD-2, including
mGLD-2, have been reported (Kwak et al., 2004; Rouhana et
al., 2005; Wang et al., 2002), the details remain to be clarified.
We thus amplified a DNA fragment carrying the entire protein-
coding region of mGLD-2 by PCR using an unfertilized mouse
oocyte cDNA library as a template. The nucleotide sequence of
the amplified DNA fragment indicated that several sequence
elements required for polyadenylation activity are conserved in
mGLD-2: three Asp residues and putative ATP-interacting
residues necessary for binding to two divalent cations and
substrate ATP involved in the enzymatic catalysis, respectively
(Fig. 1A). As compared with mouse nuclear PAPII (Raabe et
al., 1991; Zhao and Manley, 1996), mGLD2 possessed an
approximately 120-residue extra sequence at the N-terminus
and lacked a C-terminal sequence of almost 330 residues
containing the RNA-binding and Ser/Thr-rich domains, and
two bipartite nuclear localization signals (NLSs). A sequence
similar to the cyclin-recognition motif (CRM) in PAPII (Bond
et al., 2000) was also present at residues 468–471 in the C-
terminal region of mGLD-2. Noteworthy was that the
consensus sequences for bipartite NLS and leucine zipper
motif are present at residues 76–92 and 142–163 in the N-
terminal region of mGLD-2, respectively (Fig. 1A). The
catalytic and central domains of mGLD-2 shared high degrees
of sequence identities (74 and 94%) with those of Xenopus and
human GLD-2, respectively, whereas the mouse sequence was
highly divergent to the C. elegans sequence (39% identity).
Northern blot analysis indicated that two forms of mGLD-2
mRNA with sizes of 3.5 and 2.3 kb are present in all mouse
tissues tested (Fig. 1B). On the basis of the genomic DNA
sequence of mGLD-2 on the NCBI Genomic Biology database
(http://www.ncbi.nlm.nih.gov/Genomes/), three DNA frag-
ments were PCR-amplified from a mouse testicular cDNA
library using different sets of oligonucleotide primers. Sequence
analysis of the amplified fragments indicated that the protein-
coding region of the 3.5-kb form (long form) of mGLD-2
mRNA is identical to that of the 2.3-kb form (short form) of
mRNA (GenBank/EMBL accession number NM_133905).
These two mRNAs are distinguished by the length of the 3V-
untranslated region encoded by the same exon (15th exon) of
the mGLD-2 gene. Indeed, only 3.5-kb mRNA signal was
detected when a DNA fragment (probe 2) carrying the 378-bp
3V-untranslated region of the longer mRNA form was used as a
probe. These data are consistent with the recent finding that
two mRNA forms of GLD-2, which contain the same protein-
coding region, but differ in the length of the 3V-untranslated
region, are present in Xenopus oocytes and mouse and human
tissues (Rouhana et al., 2005). As expected by the expression
pattern, 54-kDa mGLD-2 was found in all tissues, despite that
the protein level was relatively low in the brain, heart, andspleen (Fig. 1C). These data suggest ubiquitous expression of
the mGLD-2 gene in the mouse tissues. It should be noted that
a 51-kDa protein immunoreactive with affinity-purified anti-
mGLD-2 antibody was also present in all mouse tissues (Fig.
1C). The 51-kDa protein was abundantly present in the brain
and relatively rich in the testis and ovary. Because 54-kDa
mGLD-2 in ovarian protein extracts was solely immunode-
pleted by antibody against the N-terminal 99-residue polypep-
tide of mGLD-2, the 51-kDa protein nonspecifically
immunoreacted with affinity-purified anti-mGLD-2 antibody.
mGLD-2 was shown to exhibit a polyadenylation activity
toward an artificial RNA substrate when an mRNA construct
encoding mGLD-2 fused to RNA-binding protein MS2 was
expressed in Xenopus oocytes (Kwak et al., 2004). In this
study, we examined nonspecific polyadenylation activity of
mGLD-2 under assay conditions where the enzyme affinity
toward RNA primers increased independently of the poly-
adenylation hexanucleotide, AAUAAA, and CPSF (Wahle,
1991). Recombinant mGLD-2 protein fused to a FLAG/HA
tag, which migrated as a 56-kDa polypeptide on SDS-PAGE,
was capable of transferring the AMP moiety from [a-32P]ATP
to oligo(A)12 RNA primer (Fig. 2A). When one of the active-
site Asp residues in mGLD-2 was point-mutated by Ala, the
mutant protein, D215A, exhibited approximately 90% reduc-
tion in activity.
As described above, the subcellular localization of mam-
malian GLD-2 is still uncertain. Immunoblot analysis indicated
that 54-kDa mGLD-2 is predominantly present in the nuclear
fractions of liver, testis and NIH3T3 cells but is also localized
at a low level in the cytoplasmic fractions (Fig. 3A). To
ascertain the localization of mGLD-2 in the nucleus, five
expression plasmids encoding fusion proteins between EGFP
and mGLD-2, PAPII, or three mGLD-2 mutants (DN94, D73–
94, and DC132) were constructed and expressed in NIH3T3
cells (Fig. 3B). Fluorescent microscopic analysis of the fusion
proteins demonstrated the nuclear localization of EGFP/
mGLD-2 and EGFP/PAPII (Fig. 3C). The EGFP/mGLD-
2DC132 fusion protein was also present in the cell nucleus,
whereas the cytoplasmic localization was obvious in the EGFP/
mGLD-2DN94 and EGFP/mGLD-2D73–94 proteins. These
data suggest that the bipartite NLS of mGLD-2 at residues 76–
92 (Fig. 1A) is probably required for the transport into the
nucleus because the EGFP/mGLD-2DN94 and EGFP/mGLD-
2D73–94 proteins lack the NLS sequence among four EGFP/
mGLD-2 fusion proteins tested (Fig. 3B).
C. elegans GLD-2 is a regulatory protein important for
normal progression through meiotic prophase and for promo-
tion of the entry into meiosis during gametogenesis (Kadyk and
Kimble, 1998; Wang et al., 2002). We thus selected mouse
oocyte as an experimental model to elucidate the functional
role(s) of mGLD-2 during meiotic maturation. Two DNA
fragments corresponding to the long form of mGLD-2 mRNA
and both long and short forms (Fig. 1B) were amplified from
total RNAs of the oocytes at GV through metaphase-II stages
by reverse transcriptase (RT)-PCR (Fig. 4A). The mRNA level
of the long form was apparently very low. When polyadenyla-
tion of two mGLD-2 mRNAs was examined by PAT assay, the
Fig. 1. Protein sequence and expression pattern of mGLD-2. (A) Amino acid sequence and schematic representation of mGLD-2. The putative residues required for
binding to two divalent cations and substrate ATP involved in the enzymatic catalysis are indicated by closed and open circles, respectively. Other possible elements
similar to the consensus sequences of the bipartite nuclear localization signal (NLS), leucine zipper motif (LZ), and cyclin-recognition motif (CRM) are underlined with
wavy, broken, and solid lines, respectively.Note thatmGLD-2 lacks an approximately 330-residueC-terminal sequence ofmousePAPII containing theRNA-binding and
Ser/Thr-rich domains, and two bipartite nuclear localization signals (NLS1 andNLS2). (B) Northern blot analysis and sequence analysis of twomGLD-2mRNAs. Total
cellular RNAs of testis (T), brain (B), lung (Lu), heart (H), liver (Li), spleen (S), kidney (K), ovary (O), and uterus (U) from adult mice were separated by agarose gel
electrophoresis, blotted, and hybridized to 32P-labeled DNA fragment corresponding to probe 1 or probe 2. Three DNA fragments were PCR-amplified from a mouse
testicular cDNA library using SEP5/SEP19, SEP50/SEP12, and SEP11/SEP12 primer sets and then sequenced. No DNA fragment was amplified when a SEP11/SEP53
primer set was used. The regions amplified by SEP5/SEP7 and SEP46/SEP18 primer sets, which are common to both short and long forms of mGLD-2 mRNA, and
specific for the long form, respectively, are also represented. Arrows indicate the location of putative polyadenylation signals. 5V-UTR, 5V-untranslated region; ORF, open-
reading frame; 3V-UTR, 3V-untranslated region. (C) Immunoblot analysis. Protein extracts (10 Ag) of mouse tissues were separated by SDS-PAGE, blotted, and probed by
affinity-purified anti-mGLD-2 or anti-h-tubulin antibody. Asterisks indicate the location of a 51-kDa protein nonspecifically immunoreactive with the anti-mGLD-2
antibody. The 54-kDa mGLD-2 protein was immunodepleted (ID) from the ovarian extracts by treatment with (+) or without () antibody against the N-terminal 99-
residue polypeptide of mGLD-2, and the resulting supernatant was subjected to immunoblot analysis using affinity-purified anti-mGLD-2 antibody, as described above.
T. Nakanishi et al. / Developmental Biology 289 (2006) 115–126 119
Fig. 2. Polyadenylation activity of mGLD-2 and its mutant D215A.
Recombinant proteins fused to FLAG/HA tag (arrows) were produced by an
in vitro transcription/translation system and subjected to immunoblot analysis
using anti-FLAG antibody as a probe. An asterisk indicates the location of a
nonspecific protein band. The enzyme activities of mGLD-2 (closed circle),
D215A (open triangle), and mock (open circle) were monitored by measuring
the incorporation of AMP from [a-32P]ATP into oligo(A)12 primer.
T. Nakanishi et al. / Developmental Biology 289 (2006) 115–126120poly(A) tail of the short form of mGLD-2 mRNA at the
metaphase-I stage was approximately 100 nucleotides longer
than those at other stages of oocyte maturation (Fig. 4B). No
significant band was detectable in the long form of mGLD-2Fig. 3. Localization of mGLD-2 in somatic, testicular, and cultured cells. (A) Immu
and NIH3T3 cells were separated by SDS-PAGE, blotted, and probed by anti-mGL
between EGFP and mGLD-2, PAPII, or three mGLD-2 mutants (DN94, D73–94, an
signal (NLS), are indicated. (C) Microscopic analysis. After transfection of expressio
a fluorescent microscope. Scale bar = 20 Am.mRNA. Despite the presence of mGLD-2 mRNA (Fig. 4A), the
protein level of mGLD-2 was negligibly low both in the
oocytes at the GV stage and in those undergoing GVBD (Fig.
4C). The metaphase-I oocytes contained only a low level of
mGLD-2, and this protein reached the highest level in the
metaphase II-arrested oocytes. These results demonstrate that
the short form of mGLD-2 mRNA is predominantly present in
the oocytes throughout meiotic maturation, and suggest that the
additional extension of the poly(A) tail of mGLD-2 mRNA
may be responsible for the protein synthesis during the
progress of oocytes from the metaphase I to metaphase II.
To examine the subcellular localization of mGLD-2 in the
oocyte, we carried out immunohistochemical analysis using
affinity-purified anti-mGLD-2 antibody. However, no rigid
data were obtained presumably owing to the low abundance of
mGLD-2 (data not shown). Consequently, polyadenylated
RNA (0.2 mg/ml) encoding mGLD-2 fused to a FLAG/HA
tag at the N-terminus was microinjected into GV-stage oocytes
in the presence of dbcAMP, an inhibitor for spontaneous oocyte
maturation. Following meiotic maturation of the oocytes in the
absence of dbcAMP, the distribution of FLAG/HA-tagged
mGLD-2 produced was investigated by immunohistochemical
analysis using anti-HA antibody (Fig. 4D). FLAG/HA-tagged
mGLD-2 was enriched in the nucleus of the GV-stage oocytenoblot analysis. Nuclear (N) and cytoplasmic (C) proteins (5 Ag) of liver, testis,
D-2 or anti-HDAC2 antibody. (B) Schematic representation of fusion proteins
d DC132). Putative functional motifs, including a bipartite nuclear localization
n plasmids, NIH3T3 cells were stained with Hoechst 33342 and observed under
Fig. 4. Delayed synthesis of mGLD-2 during oocyte maturation. (A) RT-PCR analysis. First-strand cDNA was synthesized from total RNA of oocytes at germinal
vesicle (GV), GV breakdown (BD), metaphase-I stage (MI), and metaphase-II (MII) stage, and testicular tissues (T). DNA fragments were amplified by RT-PCR
from the short (S) and long (L) forms of mGLD-2 mRNA (Fig. 1B) and mRNA for glyceraldehyde-3-phosphate dehydrogenase (G3PDH), as described in the
Materials and methods section. (B) PAT assay. The sizes of poly(A) tails of two mGLD-2 mRNAs were measured by PAT assays using total RNA from GV-, BD-,
MI-, and MII-stage oocytes and testicular tissues. (C) Immunoblot analysis. Proteins of GV-, BD-, MI-, and MII-stage oocytes (usually 50 cells per lane) were
separated by SDS-PAGE, blotted, and probed by affinity-purified anti-mGLD-2 or anti-h-tubulin antibody. An asterisk indicates the location of a 51-kDa protein
nonspecifically immunoreactive with the anti-mGLD-2 antibody. (D) Microinjection of polyadenylated RNA. Polyadenylated RNA (0.2 mg/ml) encoding mGLD-2
fused to a FLAG/HA tag was microinjected into GV-stage oocytes. The oocytes were cultured for 6 h in the presence of dbcAMP and underwent spontaneous
meiotic maturation in the absence of dbcAMP. At various maturation stages indicated, the oocytes were fixed and immunostained with anti-HA and anti-h-tubulin
antibodies. The cell nuclei were also stained with Hoechst 33342. Scale bar = 20 Am.
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These data suggest the cytoplasmic localization of mGLD-2 in
the oocytes at metaphases I and II. Moreover, mGLD-2 may be
present in the nucleus as well as in the cytoplasm of the GVand
GVBD oocytes if the protein is indeed synthesized in these
cells (Fig. 4C).
To block translation of mGLD-2 mRNA in oocytes, RNAi
was carried out by direct injection of dsRNAs into GV-stage
oocytes in the presence of dbcAMP. The reason why we used
long dsRNAs for RNAi was because mouse oocytes lack the
protein kinase PKR-mediated apoptotic response elicited by
long dsRNA in somatic cells (Svoboda et al., 2000; Yu et al.,
2004). A dsRNA, termed dsRNAi-1, homologous to the
protein-coding region of mGLD-2 was designed to target
endogenous mRNA destruction (Fig. 5A). We microinjected
dsRNAi-1 or a control dsRNA (dsRNAi-c) matching mouse
Mos cDNA (Fig. 5B). mGLD-2 and Mos mRNAs in the GV
stage-arrested oocytes in the presence of dbcAMP were
analyzed by RT-PCR 20 h after dsRNA injection (Fig. 5C).
The injections of dsRNAi-1 and dsRNAi-c showed approxi-
mately 62 and 75% reduction of mGLD-2 and Mos mRNAs
after the 20-h culture, relative to negative controls (oocytes
without dsRNA injection), respectively (arrows in Fig. 5C).
Moreover, the injection of mGLD-2 and Mos sense RNA
(sRNAi-1 and sRNAi-c, respectively) had no significant effect
on the level of the endogenous mRNA.
GV-stage oocytes, which had been injected with dsRNAi-1
or dsRNAi-c, were then cultured in vitro in the absence of
dbcAMP to undergo spontaneous meiotic maturation (Fig. 5B).GVBD was observed in most oocytes (approximately 95%) 2–
3 h after culture. As compared with oocytes without dsRNA
injection, the dsRNAi-1-injected oocytes revealed a significant
delay in meiotic maturation; 36% of total oocytes were arrested
or remained at metaphase I even after 18-h culture (Fig. 5D),
despite normal spindle formation (data not shown). RT-PCR
analysis indicated that the levels of mGLD-2 mRNA in the
metaphase-I and metaphase-II oocytes previously injected with
dsRNAi-1 are 24 and 2% of those without dsRNA injection,
respectively (arrows in Fig. 5E). Consistent with the fact that
Mos is involved in the maintenance of the metaphase-II arrest
(Colledge et al., 1994; Hashimoto et al., 1994; Wianny and
Zernicka-Goetz, 2000), 21% of total oocytes injected with
dsRNAi-c progressed to one-cell embryos with a single
pronucleus due to spontaneous parthenogenetic activation
(Fig. 5D). These data suggest that mGLD-2 may play an
important role in the progression of metaphase I to metaphase
II during oocyte maturation.
Mouse oocytes barely contain mGLD-2 at GV and GVBD
stages of meiotic maturation (Fig. 4C), as described above. To
examine whether overproduction of mGLD-2 affects oocyte
maturation, we microinjected polyadenylated mGLD-2 RNA
into GV-stage oocytes, using polyadenylated RNAs of mutant
protein D215A and EGFP as controls (Fig. 6A). When the
oocytes were cultured in the presence of dbcAMP for 6 h and
then underwent spontaneous maturation in the absence of
dbcAMP, the mGLD-2 RNA (1.0 mg/ml)-injected oocytes
were mostly (88%) arrested at metaphase I after 18-h culture
(Fig. 6B). The oocytes injected with polyadenylated D215A or
Fig. 5. Arrest of oocyte maturation by impaired synthesis of mGLD-2. (A) Targeted regions for endogenous mRNA destruction. Two dsRNAs, dsRNAi-1 and
dsRNAi-c, homologous to the protein-coding and 3V-untranslated regions of mGLD-2 and Mos, respectively, were designed to target endogenous mRNA destruction.
Single-strand sense RNAs (sRNAi-1 and sRNAi-c) covering the same regions were also synthesized in vitro. Arrows indicate the location of oligonucleotide primers
used for RT-PCR. (B) Schematic diagram of the procedures for RNAi. Germinal vesicle (GV)-stage oocytes were injected with sRNA or dsRNA, incubated in the
presence of dbcAMP for 20 h, cultured in the absence of dbcAMP for 16–18 h, and stained with Hoechst 33342. The GV breakdown (BD)-, metaphase I (MI)-,
metaphase II (MII)-, and pronuclear (PN)-stage oocytes were then observed microscopically. (C) Specific reduction of endogenous mRNA in GV-stage oocytes by
RNAi. After injection of sRNA (s) or dsRNA (ds), the GV-stage oocytes were incubated for 20 h in the presence of dbcAMP and then subjected to RT-PCR analysis
using uninjected oocytes (Un) as a control. Arrows indicate the reduction of mGLD-2 and Mos mRNAs. (D) Arrest of oocyte maturation at the MI stage. After
culture in the absence of dbcAMP, the stages of oocyte maturation were microscopically assessed. The oocytes injected with sRNA or dsRNA at the GV-stage still
remained at the GV stage, developed into the MI-, MII-, and PN-stage oocytes, or caused fragmentation (approximately 10% of total oocytes). The relative ratios of
the MI- and PN-stage oocytes to total oocytes injected with sRNA or dsRNA are expressed as the means T SE, where n  3. Numbers of oocytes examined are as
follows: 48, 181, and 94 oocytes for sRNAi-1 (n = 3), dsRNAi-1 (n = 9), and dsRNAi-c (n = 8), respectively. Uninjected oocytes (131 cells, n = 9) were used as a
control. *Differences between ‘‘uninjected’’ and ‘‘dsRNAi-1’’ and between ‘‘uninjected’’ and ‘‘dsRNAi-c’’ are statistically significant ( P < 0.005, Student’s t test).
(E) Reduction of endogenous mGLD-2 mRNA during oocyte maturation by RNAi. Total RNAwas prepared from the GV-, MI-, and MII-stage oocytes previously
uninjected (Un) or injected (In) with dsRNAi-1 and subjected to RT-PCR analysis as described above. Arrows indicate the reduction of mGLD-2 mRNA in the MI-
and MII-stage oocytes.
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tion. Thus, overproduction of mGLD-2 also prevents the
oocytes from progressing from metaphase I to metaphase II.
Some mRNAs, including those of cyclin B1, Mos, and h-
catenin, are known to be polyadenylated during oocyte
maturation (Gebauer et al., 1994; Oh et al., 2000; Tay et al.,
2000). To ascertain the effects of enhanced production of
mGLD-2 on the poly(A) tails of these three mRNAs, PAT
assays for polyadenylated RNA-injected oocytes were carried
out (Fig. 6C). The poly(A) tails of cyclin B1, Mos, and h-
catenin mRNAs in the GV-arrested oocytes injected with
polyadenylated mGLD-2 RNA were approximately 50–100
nucleotides longer than those in the oocytes uninjected and
injected with polyadenylated D215A RNA. No significant
difference of the poly(A) tail in length was found at the
metaphase-I stage among the uninjected and polyadenylated
mGLD-2 and D215A RNA-injected oocytes. Thus, the
overproduction of mGLD-2 in the GV-stage oocytes results
in the additional poly(A) elongation of at least cyclin B1, Mos,and h-catenin mRNAs, suggesting that the artificial, unneces-
sary extension of mRNA poly(A) tails at the GV stage may be
implicated in the metaphase-I arrest of oocytes.
Discussion
This study describes the nuclear and cytoplasmic localiza-
tion of mGLD-2 in somatic, testicular, and cultured cells.
Transient expression analysis of EGFP/mGLD-2 chimeric
proteins in NIH3T3 cells demonstrates that the region required
for guiding mGLD-2 to the nucleus is present within the 22-
residue sequence containing a putative bipartite NLS at
residues 76–92 (Figs. 1 and 3). Although mGLD-2 is also
capable of residing in the nucleus of the GV-stage oocytes, the
mouse oocytes have a specialized program for mGLD-2 in
which its mRNA is effectively translated after GVBD during
oocyte maturation (Fig. 4). Both artificial impairment and
enhancement of mGLD-2 synthesis lead to the arrest of oocyte
maturation at the metaphase-I stage (Figs. 5 and 6). Thus, in the
Fig. 6. Arrest of oocyte maturation by overproduction of mGLD-2. (A) Schematic diagram of the procedures for mGLD-2 overproduction. Germinal vesicle (GV)-
stage oocytes were injected with polyadenylated RNA, incubated in the presence of dbcAMP for 6 h, cultured in the absence of dbcAMP for 16–18 h, and stained
with Hoechst 33342. The stages of oocyte maturation were then assessed microscopically. (B) Arrest of oocyte maturation at the MI stage. After culture in the
absence of dbcAMP, the maturation stages of oocytes previously injected with polyadenylated RNA (0.2 or 1.0 mg/ml) were assessed. Data are expressed as the
means T SE, where n  3. Numbers of oocytes examined are as follows: 42, 89, 40, and 91 oocytes for polyadenylated RNAs of 0.2 mg/ml mGLD-2 (n = 3), 1.0 mg/
ml mGLD-2 (n = 5), 0.2 mg/ml D215A (n = 3, see Fig. 2), and 1.0 mg/ml D215A (n = 6), respectively. Oocytes previously uninjected (78 cells, n = 4) or injected
with 1.0 mg/ml EGFP (35 cells, n = 3) were used as controls. Note that all oocytes underwent GVBD and were arrested at the MI or MII stage after culture in the
absence of dbcAMP for 16–18 h. (C) PAT assay. GV-stage oocytes were injected with and without (Un) polyadenylated RNA, incubated in the presence of dbcAMP
for 6 h, and cultured in the absence of dbcAMP for 7 h (MI-stage oocytes). The sizes of poly(A) tails of cyclin B1, Mos, h-catenin, and h-actin as a negative control
were measured by PAT assays using total RNA from the GV- and MI-stage oocytes. Note that overproduction of mGLD-2 in the GV-stage oocytes results in the
additional poly(A) elongation of cyclin B1, Mos, and h-catenin mRNAs.
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Xenopus proteins presumably participates in cytoplasmic
polyadenylation of a subset of pre-existing mRNAs essential
for the meiotic maturation.
Computer-aided search on the PROSITE database of
protein families and domains indicates that the sequences of
C. elegans and Xenopus GLD-2 contain a single set of
potential bipartite NLS at residues 1071–1087 and 99–115
(or 100–116) in the C- and N-terminal regions, respectively
(data not shown). These two GLD-2 proteins have been
shown to localize in the cytoplasm of embryos and cultured
cells (Barnard et al., 2004; Wang et al., 2002), although
Xenopus GLD-2 is both cytoplasmic and nuclear in the stage-
VI oocytes (Rouhana et al., 2005). Our data represented in
this study demonstrate the presence of mGLD-2 in the
cytoplasm of mouse oocytes at metaphases I and II (Fig.
4). However, the subcellular destination of mGLD-2 to the
ooplasm results from the translational control of the mGLD-2
mRNA. Indeed, mGLD-2 is enriched in the nucleus when
polyadenylated mGLD-2 RNA is injected into mouse oocytes
at the GV (Fig. 4) and pronuclear stages (data not shown).
Because Xenopus GLD-2 resides in a protein complex of
cytoplasmic polyadenylation machinery even in the oocytes
prior to GVBD (Barnard et al., 2004), the functional role of
mGLD-2 during oocyte maturation may be similar to but
distinguishable from that of Xenopus GLD-2.
The presence of mGLD-2 in the cell nucleus (Fig. 3) is
intriguing since this protein contains a putative CRM sequence,
Lys–Arg–Asp–Leu, at the position similar to that of PAPII(Fig. 1). The CRM of canonical nuclear PAP (PAPI and PAPII)
is shown to interact with both G1- and G2-type cyclins and
mediate phosphorylation of PAP by cyclin-dependent kinases
(Bond et al., 2000). Furthermore, the PAP hyperphosphoryla-
tion during mitosis and oocyte maturation results in the loss of
the polyadenylation activity (Colgan et al., 1998). It is thus
conceivable that the maintenance of normal level of PAP
phosphorylation is probably mediated via the CRM throughout
the cell cycle and that the inhibition of PAP may prevent
incorrect lengthening of mRNA poly(A) tails in the cytoplasm
of M-phase cells (Bond et al., 2000; Colgan et al., 1998). Our
preliminary experiments have indicated that the molecular
mass of mGLD-2 exogenously expressed by injection of the
polyadenylated RNA is approximately 1 kDa higher in the
cytoplasm of the metaphase-I and -II oocytes than in the
nucleus of the GV-stage oocytes (data not shown), implying
possible phosphorylation of mGLD-2 in the cytoplasm of the
metaphase oocytes. Even so, mGLD-2 must be functionally
active, as described in Figs. 5 and 6. Thus, the regulation of the
polyadenylation activity by protein (hyper)phosphorylation
may be different between mGLD-2 and canonical PAP in the
oocytes.
Translational activation of mRNAs in the cytoplasm of
oocytes is basically coupled with their polyadenylation
(Richter, 2000). In the present study, the poly(A) tail of
mGLD-2 mRNA is elongated at the metaphase-I stage and then
deadenylated at the metaphase-II stage of mouse oocytes (Fig.
4B). However, mGLD-2 synthesis occurs in the metaphase-I
oocytes at a detectable level, and the protein is accumulated at
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There is an apparent discrepancy in the time between poly(A)
tail lengthening and protein synthesis. The delayed synthesis of
mGLD-2 may be explained by a possible continuation of the
poly(A) tail lengthening or maintenance of the elongated
poly(A) tail during the oocyte transition from the metaphase-I
to metaphase-II stages. Indeed, the GVBD, metaphase-I, and
metaphase-II oocytes are recovered 2–3, 7–8, and 16–18
h after culture of the GV-stage oocytes in the absence of
dbcAMP (Fig. 5B), respectively, and are analyzed by RT-PCR
and immunoblotting (Figs. 5B and C). If the above possibility
is correct, mGLD-2 is probably accumulated in the oocytes
until the metaphase-II stage.
The precise translational control of mGLD-2 is essential
for oocyte maturation because meiotic maturation is inhibited
or delayed by both knockdown and overproduction of
mGLD-2 in the GV-stage oocytes (Figs. 5 and 6). The
overproduction leads to aberrant polyadenylation of cyclin
B1, Mos, and h-catenin mRNAs at the GV stage (Fig. 6C).
Then, translational activation of these three mRNAs may
occur, which results in the metaphase-I arrest of the oocytes
(Fig. 6B). In some experiments, we examined the effects of
RNAi-induced knockdown of mGLD-2 on poly(A) tail
lengths of the above mRNAs at the GV and metaphase-I
stages. Although poly(A) tail lengthening was expected to be
defective in the mGLD-2-knockdown oocytes, the poly(A)
tails of cyclin B1, Mos, and h-catenin mRNAs were
apparently elongated normally at the metaphase-I stage (data
not shown). A possible reason for the unexpected results is
because more than 20% of mGLD-2 mRNA still remain in
the metaphase-I oocytes after dsRNA-1 injection (Fig. 5E). A
small amount of mGLD-2 appears to be synthesized in the
metaphase-I oocytes, which may be implicated in the delay in
meiotic maturation (Fig. 5D). Another reason may be due to
the sensitivity of PAT assay. Despite a low abundance, an
elongated mRNA poly(A) tail can be amplified by this assay
system. Thus, further experiments remain necessary to clarify
the effects of mGLD-2 knockdown on poly(A) tail lengthen-
ing in the metaphase-I oocytes.
As described above, the accumulation of mGLD-2 in the
oocytes starts at the time when the poly(A) tail lengthening of
mGLD-2 mRNA occurs (Fig. 4). Despite the presence of
mGLD-2 mRNA, the protein level is negligibly low in the
GV and GVBD oocytes, suggesting that this mRNA is most
likely under translational control during oocyte maturation.
Thus, the oocytes appear to require the precise translation of
mGLD-2 mRNA during the transition from metaphase I to
metaphase II. This probability may be supported by the fact
that both knockdown and overproduction of mGLD-2 result
in the arrest and/or delay of oocyte maturation at the
metaphase-I stage.
On the basis of the interaction of GLD-2 with known
polyadenylation factors, at least two distinct polyadenylation
complexes, G and MP complexes, have been proposed to exist
in the cytoplasm of Xenopus stage-VI oocytes (Barnard et al.,
2004; Rouhana et al., 2005). GLD-2 is included in the G-
complex together with CPEB, CPSF, and possibly symplekin,whereas the MP complex contains CPEB, maskin, and Pumilio.
Rouhana et al. (2005) suggest that actively and inactively
translated mRNAs may be partitioned between the G and MP
complexes during oocyte maturation. In the mouse brain,
mGLD-2 mRNA is shown to co-localize with those of CPEB
and Pumilio presumably involved in synaptic plasticity,
implying an importance of mGLD-2 in the translational
activation at synapses (Rouhana et al., 2005). Our data show
that meiotic maturation of the mouse oocytes requires the
precise translational control of mGLD-2 (Figs. 5 and 6), as
described above. The low abundance or absence of this enzyme
at the GV and GVBD stages seems to prevent the substrate
mRNAs from starting the polyadenylation-induced translation.
We thus suggest that mGLD-2 may act as a positive regulator
in the progression of metaphase I to metaphase II during oocyte
maturation.
It has been reported that CPEB, CPSF100, and maskin
as the components of the G and MP complexes are present
in the GV- through metaphase II-stage mouse oocytes
(Hodgman et al., 2001). Because maskin is known to
interact with translationally repressed mRNAs (Richter,
2000), cytoplasmic polyadenylation in the oocytes may be
conducted by mGLD-2 in the G complex at the metaphases
I and II, together with maskin-mediated repression. This
coordinated regulation of mRNA poly(A) tails may help to
ensure the progression of oocyte maturation. Nevertheless,
the substrate mRNAs for mGLD-2 in the G complex
remain to be identified. Some of the mRNA targets of
oocyte mGLD-2 are possibly mRNAs encoding regulatory
proteins involved in the cell cycle progression and the
organization of spindles and microfilaments, including
CKS2 (Spruck et al., 2003) and formin-2 (Leader et al.,
2002). Indeed, mutant mice lacking CKS2 or formin-2
show the oocyte arrest at the metaphase-I stage.
Targeting of C. elegans GLD-2 to specific mRNAs is
probably regulated by the binding partner GLD-3 because
GLD-3 belongs to a Bicaudal-C family of RNA-binding
proteins (Wang et al., 2002; Wessely et al., 2001). In Xenopus
GLD-2, CPEB, CPSF, and possibly symplekin in the cytoplas-
mic polyadenylation machinery likely direct GLD-2 to recruit
to specific mRNAs containing the CPE signal (Barnard et al.,
2004). Thus, to elucidate the functional role(s) of mGLD-2,
both the post-translational modification of mGLD-2 and the
interaction of this protein with other unknown proteins remain
to be examined. The leucine zipper motif present in mGLD-2
may help to know a possible interaction(s) with regulatory
proteins, DNA, and/or RNA.
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